Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers
Clinical trial NCT03564158 · COMPLETED
Trial details
- NCT number
- NCT03564158
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2018-11-19
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.